Sang-Woo Park

Vorstandsvorsitzender bei NKMAX CO., LTD.

Vermögen: 671 775 $ am 31.05.2024

55 Jahre

Health Technology

Consumer Services

Aktive Positionen von Sang-Woo Park

Unternehmen	Position	Beginn	Ende
NKMAX CO., LTD.	Vorstandsvorsitzender	31.03.2023	-
	Vorsitzender	14.01.2002	-
	Gründer	14.01.2002	-
ATGen America, Inc.	Vorstandsvorsitzender	01.02.2014	-
ATGen America, Inc.	Vorsitzender	01.02.2014	-
ATGen Canada, Inc.	Vorstandsvorsitzender	01.09.2013	-
ATGen Canada, Inc.	Vorsitzender	01.09.2013	-
Atgen H&D Atgen H&D Pharmaceuticals: OtherHealth Technology Atgen H&D develops protein products. Sang-Woo Park has been the CEO of the South Korean company since 2016.	Vorstandsvorsitzender	01.01.2016	-
NKMAX Co., Ltd. NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea.	Vorsitzender	01.01.2002	-
	Vorstandsvorsitzender	01.01.2002	-
	Gründer	01.01.2002	-
	Direktor/Vorstandsmitglied	01.01.2002	-
Nkmax H&D Co. Ltd.	Vorstandsvorsitzender	01.06.2016	-
Nkmax H&D Co. Ltd.	Vorsitzender	01.06.2016	-
coAsia Biotech Corp. coAsia Biotech Corp. BiotechnologyHealth Technology Part of NKMAX Co., Ltd. (South Korea), coAsia Biotech Corp. manufactures biological products. Sang-Woo Park has been the CEO of the Thai company since 2016. coAsia Biotech was acquired by NKMAX Co., Ltd. (South Korea) on February 28, 2018 for $0.10 million.	Vorstandsvorsitzender	01.04.2016	-
	Vorsitzender	01.04.2016	-
Atgen Japan	Vorstandsvorsitzender	01.09.2017	-
Atgen Japan	Vorsitzender	01.09.2017	-
Nkmax Japan, Inc.	Vorstandsvorsitzender	01.11.2017	-
Nkmax Japan, Inc.	Vorsitzender	01.11.2017	-

Karriereverlauf von Sang-Woo Park

Ehemalige bekannte Positionen von Sang-Woo Park

Unternehmen	Position	Beginn	Ende
░░░░░ ░░░░░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░	░░░░░░░░░░
	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░	░░░░░░░░░░
	░░░░░░░░	░░░░░░░░░░	-
	░░░░░░░	░░░░░░░░░░	░░░░░░░░░░
░ ░░░ ░░░░ ░░░░	░░░░░░░░░░░░░░ ░░░░░░	░░░░░░░░░░	-
░ ░░░ ░░░░ ░░░░	░░░░░ ░░░░░░░░░ ░░░░░░░	░░░░░░░░░░	-

Ausbildung von Sang-Woo Park

Korea University

Undergraduate Degree

Statistik

International

Südkorea	7
Vereinigte Staaten	3
Japan	3

Operativ

Chief Executive Officer	11
Chairman	10
Director/Board Member	4

Sektoral

Health Technology	6
Consumer Services	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Unternehmensverbindungen

Börsennotierte Unternehmen	2
J WAY CO., LTD.	Consumer Services
NKMAX CO., LTD.	Health Technology

Private Unternehmen	9
ATGen Canada, Inc.
ATGen America, Inc.
Atgen H&D Atgen H&D Pharmaceuticals: OtherHealth Technology Atgen H&D develops protein products. Sang-Woo Park has been the CEO of the South Korean company since 2016.	Health Technology
NKMAX Co., Ltd. NKMAX Co., Ltd. Pharmaceuticals: MajorHealth Technology NKMAX Co., Ltd. engages in the manufacture and sale of pharmaceutical products. It operates through the following business divisions: Immunity Cell Cure, Immunodiagnosis Kit, Health Functional Foods, and Bio Research. The company was founded on January 14, 2002 and is headquartered in Seongnam-si, South Korea.	Health Technology
coAsia Biotech Corp. coAsia Biotech Corp. BiotechnologyHealth Technology Part of NKMAX Co., Ltd. (South Korea), coAsia Biotech Corp. manufactures biological products. Sang-Woo Park has been the CEO of the Thai company since 2016. coAsia Biotech was acquired by NKMAX Co., Ltd. (South Korea) on February 28, 2018 for $0.10 million.	Health Technology
Nkmax H&D Co. Ltd.
Atgen Japan
NKGen Biotech, Inc. NKGen Biotech, Inc. BiotechnologyHealth Technology NKGen Biotech, Inc. is a biotechnology company which engages in harnessing the immune system through natural killer cell therapies. It develops a proprietary stabilizing peptide, monoclonal antibodies, and recombinant proteins for research use. The company was founded in 2002 and is headquartered in Santa Ana, CA.	Health Technology
Nkmax Japan, Inc.

Sehen Sie sich die Unternehmensverbindungen an